Investigation of COVID-19 associated neurological comorbidities
Recruiting
- Conditions
- neurological comorbidityCOVID-19U07.1COVID-19, virus identified
- Registration Number
- DRKS00023312
- Lead Sponsor
- niversitätsklinikum Essen
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 250
Inclusion Criteria
Confirmed Infection with COVID-19
age >= 18 years
Signed Informed consent
Exclusion Criteria
No COVID-19 Infection
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Registration of neurological comorbidity in COVID-19 patients<br>
- Secondary Outcome Measures
Name Time Method Analysis of the pathological mechanism of neurological comorbidity
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways link SARS-CoV-2 infection to neurological comorbidities in DRKS00023312?
How do standard-of-care antiviral therapies impact neurological outcomes in NEUROCOV-19 patients?
Which biomarkers correlate with severe neurological complications in DRKS00023312 observational cohort?
What adverse neurological events are reported in DRKS00023312 compared to other post-COVID-19 studies?
How does neuroinflammation in DRKS00023312 relate to cytokine profiles in SARS-CoV-2-induced encephalopathy?